Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted.
But it was busy working on something else.
Moderna-Merck cancer vaccine trial succeeds
- Moderna and Merck breakthrough could usher in wave of cancer vaccines TimesLIVE —
- What is Moderna’s new cancer vaccine and how big a breakthrough is it? Irish Times —
- Moderna-Merck may spark cancer vaccine wave The Economic Times —
- Moderna, Merck cancer vaccine scores big win in late-stage melanoma trial Business Standard —
- Moderna, Merck breakthrough could usher in wave of cancer vaccines Rappler —